RE: RE: Proteomics28 Mar 2019 22:21
There is no mention in the RNS about phase 3 trials? The RNS stated:
Dr Suzanne Dilly, CEO of ValiSeek, commented:
"Progressing ValiSeek to the next phase of development is an exciting prospect, and with two partners already confirmed, I look forward to concluding arrangements to start the final clinical trials"
2 partners with letters of intent? Exciting prospects; I look forward to...
Forward looking statements.